Chapter

The Pharmacokinetics and Clinical Therapeutics of the Antiepileptic Drugs

Mark Cook and Simon Shorvon

in Oxford Textbook of Epilepsy and Epileptic Seizures

Published on behalf of Oxford University Press

Published in print December 2012 | ISBN: 9780199659043
Published online December 2012 | e-ISBN: 9780191751363 | DOI: http://dx.doi.org/10.1093/med/9780199659043.003.0026

Series: Oxford Textbook of

The Pharmacokinetics and Clinical Therapeutics of the Antiepileptic Drugs

Show Summary Details

Preview

There are 23 first and second antiepileptic drugs in current usage, 15 of which were licensed since 1989. An understanding of their pharmacokinetics and pharmacology is important for clinical therapeutics. In this chapter the following anti epileptic drugs are considered: carbamazepine, clobazam, clonazepam, eslicarbazepine, ethosuxumide, felbamate, gabapentin, lacosamide, lamotrigine, leveracetam, phenobarbital, phenytoin, primidone, oxcarbazepine, pregabalin, retigabine, rufinamide, stiripentol, tiagabine, topiramate, valproate, vigabatrin, and zonisamide. Brief details are provided of: history of drug introduction, mechanism of action, pharmacokinetic properties, drug interactions, side effects, effectiveness, indications, preparations, dosage and blood level monitoring. The information is given in a concise form to assist physicians in their clinical practice.

Chapter.  9890 words. 

Subjects: Neurology ; Pharmacology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.